NSAIDs carry two FDA black box warnings: serious GI bleeding and ulcers (which can occur without warning symptoms), and increased risk of heart attack and stroke — both of which increase with longer use and higher amounts. Kidney toxicity is a third serious risk, particularly in patients with existing kidney disease, heart failure, or who take diuretics.
NSAID Side Effects: Common, Serious & Long-Term
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used medications in the world, taken for pain, fever, and inflammation. Common NSAIDs include ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn), meloxicam (Mobic), and celecoxib (Celebrex). They are available both over the counter and by prescription.
Despite their widespread use and perception as mild medications, NSAIDs carry serious risks that are frequently underestimated — including GI bleeding, cardiovascular events, and kidney damage — all of which are reflected in FDA black box warnings on prescription formulations. Understanding these risks is essential for anyone using NSAIDs, especially beyond short-term occasional use.
How NSAIDs Work — and Why Side Effects Occur
NSAIDs work by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for producing prostaglandins and thromboxanes throughout the body. Prostaglandins mediate inflammation, pain, and fever — reducing them is the therapeutic goal. However, prostaglandins also serve essential protective functions in the stomach (maintaining the mucosal barrier), kidneys (regulating blood flow), and cardiovascular system (balancing vasodilation and platelet aggregation).
COX-1 is the constitutively expressed isoform primarily responsible for gastroprotective prostaglandins and platelet-activating thromboxane. COX-2 is inducible and primarily responsible for inflammatory prostaglandins. Traditional non-selective NSAIDs (ibuprofen, naproxen) inhibit both; celecoxib selectively inhibits COX-2. This selectivity reduces GI risk but shifts the thromboxane/prostacyclin balance in a pro-thrombotic direction, explaining why COX-2 inhibitors carry cardiovascular risk.
Common Side Effects
- GI upset, heartburn, and nausea — Inhibition of COX-1 reduces gastric prostaglandin E2 production, which normally stimulates mucus secretion and bicarbonate output and inhibits acid secretion. Without this protection, gastric acid more readily irritates the stomach lining, causing discomfort, heartburn, and nausea. Taking NSAIDs with food reduces but does not eliminate this risk.
- Dyspepsia (indigestion) — Upper abdominal discomfort, bloating, and early satiety are common GI complaints and frequently prompt patients to discontinue NSAID use.
- Fluid retention and mild edema — NSAIDs impair prostaglandin-mediated sodium and water excretion by the kidneys, causing mild fluid retention that can manifest as swelling in the ankles and feet.
- Elevated blood pressure — The same renal mechanism that causes fluid retention also impairs vasodilatory prostaglandins, raising blood pressure. NSAIDs can blunt the effect of antihypertensive medications, particularly ACE inhibitors, ARBs, and diuretics.
- Headache — Paradoxically, frequent NSAID use for headaches can lead to medication overuse headache (MOH), also called rebound headache, in which headaches become more frequent the more NSAIDs are used.
- Dizziness and tinnitus — Particularly associated with salicylates and higher-amount NSAID use; tinnitus (ringing in the ears) is a sign of salicylate toxicity.
Serious and Rare Side Effects
⚠ FDA Black Box Warning: NSAIDs increase the risk of serious gastrointestinal events (GI bleeding, ulceration, perforation) and serious cardiovascular events (heart attack, stroke) — both of which can be fatal. GI complications can occur without warning symptoms even in patients with no prior GI history. Seek emergency care for vomiting blood, black tarry stools, severe abdominal pain, or signs of heart attack or stroke.
GI Bleeding and Ulcers — FDA Black Box Warning
NSAIDs cause GI ulcers and bleeding through two mechanisms: a direct topical irritant effect and, more significantly, the systemic loss of prostaglandin-mediated gastric protection. This allows stomach acid to erode the mucosal lining, creating ulcers that can bleed, perforate, or cause obstruction. Critically, up to 50–80% of serious NSAID-associated GI events occur without any prior warning symptoms — meaning patients can experience a major GI bleed without having had pain or heartburn beforehand. Risk increases with age, prior ulcer history, anticoagulant use, SSRI use, and corticosteroid co-administration.
Cardiovascular Events (MI, Stroke) — FDA Black Box Warning
All NSAIDs (including selective COX-2 inhibitors like celecoxib) increase the risk of serious thrombotic cardiovascular events — heart attacks and strokes — that can be fatal. The mechanism involves shifting the prostacyclin/thromboxane balance: NSAIDs suppress cardioprotective prostacyclin (a vasodilator and platelet inhibitor produced by endothelial cells) while COX-2 inhibitors also suppress prostacyclin but spare COX-1-mediated thromboxane, making platelets relatively more pro-aggregatory. Risk is highest in patients with pre-existing heart disease, atherosclerosis, or multiple cardiovascular risk factors. Even short-term use (as few as days to weeks) has been associated with elevated risk in vulnerable patients.
Renal Toxicity — Acute and Chronic
NSAIDs inhibit prostaglandin synthesis in the kidney, reducing afferent arteriolar dilation that is essential for maintaining glomerular filtration in states of low perfusion pressure (dehydration, heart failure, liver cirrhosis, chronic kidney disease). In at-risk patients, NSAIDs can precipitate acute kidney injury (AKI) within days of starting therapy. Signs include decreased urine output, swelling, and rising creatinine on laboratory testing. In patients with normal kidneys but chronic use, NSAIDs can contribute to hypertensive nephrosclerosis and analgesic nephropathy over years.
Hyperkalemia
By reducing aldosterone-stimulating prostaglandins in the kidney, NSAIDs can elevate potassium levels, particularly when combined with ACE inhibitors, ARBs, potassium-sparing diuretics, or trimethoprim. High potassium can cause dangerous cardiac arrhythmias.
Hepatotoxicity
Clinically significant liver injury from NSAIDs is rare but documented. Diclofenac has the highest hepatotoxicity signal among NSAIDs. Routine liver enzyme monitoring is not standard for most NSAID users, but patients should be aware of signs of liver injury (jaundice, dark urine, right upper quadrant pain).
Long-Term Effects
- Chronic kidney disease progression — Regular long-term NSAID use is associated with an increased risk of developing and worsening chronic kidney disease (CKD), particularly in patients with pre-existing renal impairment, hypertension, or diabetes.
- Cumulative cardiovascular risk — The thrombotic cardiovascular risk is dose-dependent and duration-dependent. Longer courses and higher amounts in patients with pre-existing cardiovascular disease confer substantially higher absolute risk. For these patients, alternatives to NSAIDs should be discussed with the prescriber whenever possible.
- GI damage — With chronic use, the risk of clinically silent mucosal damage accumulates. Endoscopic studies in chronic NSAID users show gastric erosions in a significant proportion even without symptoms. Proton pump inhibitors (PPIs) are often co-prescribed for gastroprotection in high-risk patients on chronic NSAIDs.
- Medication overuse headache — Patients who regularly use any analgesic (including NSAIDs) for headaches more than 10–15 days per month can develop a cycle of rebound headaches that become increasingly frequent and medication-dependent.
- Cardiovascular effect on heart failure — NSAIDs cause sodium and water retention and can precipitate or worsen heart failure, reduce the effectiveness of diuretics, and increase hospitalizations for decompensated heart failure.
Who Is Most at Risk
- Elderly patients (65+) — Reduced kidney reserve, higher prevalence of cardiovascular and GI comorbidities, polypharmacy interactions, and lower body mass all increase NSAID risk. NSAIDs should be used with particular caution or avoided in older adults.
- Patients with kidney disease — Any degree of pre-existing CKD increases the risk of NSAID-induced AKI and further nephron loss.
- Patients with heart disease or heart failure — Pre-existing cardiovascular disease or heart failure dramatically increases the risk from NSAID-related cardiovascular events and fluid retention.
- Patients on anticoagulants (warfarin, apixaban, rivaroxaban) — NSAIDs impair platelet function and damage the GI mucosa, significantly increasing bleeding risk when added to anticoagulant therapy.
- Patients on SSRIs — SSRIs impair platelet serotonin-dependent aggregation; combined with an NSAID's COX-1 inhibition, the risk of GI bleeding is additive or synergistic.
- Patients on corticosteroids — Corticosteroids impair GI mucosal healing; combined with NSAIDs, the risk of peptic ulcer disease and GI bleeding is substantially increased.
- Patients with prior peptic ulcer disease — History of GI ulcers significantly elevates the risk of recurrence with NSAID use; these patients should discuss PPI co-prescription or NSAID alternatives with their prescriber.
- Patients on ACE inhibitors or ARBs — The combination is potentially nephrotoxic (the "triple whammy" when a diuretic is added) and NSAIDs blunt the antihypertensive effect of these medications.
Managing Side Effects
Use NSAIDs at the lowest effective amount for the shortest necessary duration. For chronic pain management, discuss non-NSAID alternatives with your prescriber, including acetaminophen, topical NSAIDs, or non-drug approaches. Always inform your prescriber and pharmacist of all other medications you take, including over-the-counter NSAIDs.
- GI protection — Take with food; for high-risk patients (elderly, prior ulcer, anticoagulant use), your prescriber may recommend a proton pump inhibitor (omeprazole, pantoprazole) as gastroprotection.
- Stay well hydrated — Dehydration dramatically amplifies kidney risk; maintain adequate fluid intake, especially in hot weather, illness, or exercise.
- Topical NSAIDs — Topical diclofenac (Voltaren gel) delivers anti-inflammatory drug to superficial joints with minimal systemic absorption and substantially lower systemic GI and cardiovascular risk — a useful option for localized joint pain.
- Avoid combining NSAIDs — Never take two NSAIDs simultaneously (e.g., ibuprofen and naproxen, or OTC ibuprofen while prescribed celecoxib) as this compounds risk without additional benefit.
- Monitor blood pressure — If you take antihypertensives and need regular NSAID use, check blood pressure more frequently and inform your prescriber.
- Recognize GI warning signs — Black or tarry stools, vomiting blood or material that looks like coffee grounds, and severe abdominal pain are emergencies requiring immediate medical evaluation.
- Recognize cardiovascular warning signs — Chest pain, jaw pain, left arm pain, sudden shortness of breath, facial drooping, arm weakness, or sudden speech difficulty require calling 911 immediately.
Frequently Asked Questions
What are the most common NSAID side effects?
The most common NSAID side effects are gastrointestinal — stomach upset, heartburn, nausea, and abdominal discomfort. These occur because NSAIDs inhibit prostaglandin synthesis in the stomach lining, reducing the protective mucus barrier. Taking NSAIDs with food can reduce GI discomfort, but does not fully prevent the underlying mucosal vulnerability that leads to ulcer and bleeding risk.
What are the FDA black box warnings for NSAIDs?
All prescription NSAIDs carry two FDA black box warnings. The first is for serious gastrointestinal events — GI bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning symptoms and can be fatal. The second is for serious cardiovascular events — increased risk of heart attack (myocardial infarction) and stroke, which can also be fatal. These risks increase with longer duration of use and in patients with pre-existing cardiovascular or GI risk factors. NSAIDs are contraindicated for pain relief immediately before and after coronary artery bypass graft (CABG) surgery.
Can NSAIDs damage the kidneys?
Yes. NSAIDs reduce kidney blood flow by blocking prostaglandins that help dilate the renal afferent arteriole. In people who depend on these prostaglandins to maintain kidney perfusion — including patients with chronic kidney disease, heart failure, dehydration, or those on diuretics — NSAIDs can precipitate acute kidney injury. Long-term use can contribute to chronic kidney disease progression. NSAIDs should be used with particular caution in anyone with known kidney disease or risk factors.
Is celecoxib safer for the stomach than other NSAIDs?
Celecoxib (Celebrex) selectively inhibits COX-2, sparing COX-1 which is responsible for the stomach's protective prostaglandins. This makes celecoxib less likely to cause GI ulcers and GI bleeding than non-selective NSAIDs like ibuprofen or naproxen, particularly with short-term use. However, celecoxib still carries cardiovascular risk and still carries the FDA black box warnings for both GI and cardiovascular events. Patients with stomach concerns but not significant cardiovascular disease may benefit most from celecoxib relative to non-selective NSAIDs.
Related Drugs in This Class
⚠ This article is for informational purposes only and does not constitute medical advice. Seek emergency medical care for signs of GI bleeding (black stools, vomiting blood), heart attack (chest pain, jaw pain, shortness of breath), or stroke (sudden facial droop, arm weakness, speech difficulty). Always consult your prescriber before starting or continuing NSAIDs if you have cardiovascular, kidney, or GI risk factors.